You are here: Industry Insights > Vibalogics

News List

Vibalogics Advances Growth with Leadership Hires contractpharma
July 19, 2021
Vibalogics, a global contract development and manufacturing organization (CDMO) specializing in the production of oncolytic viruses, viral vectors, and vaccine virotherapy products, has made key senior U.S.-based hires to the global leadership team.
Vibalogics Expands Manufacturing Capacity contractpharma
June 15, 2021
Vibalogics, a global contract development and manufacturing organization (CDMO), initiated the first stage of a $50 million investment at its Cuxhaven, Germany facility, expanding early-to-late phase clinical virotherapy manufacturing capacity.
Vibalogics invests an additional $50 million to further expand cGMP manufacturing capacity for viral vectors firstwordpharma
June 10, 2021
Vibalogics, a global contract development and manufacturing organization (CDMO), has today announced that it has initiated the first stage of a planned $50 million dollar investment at its Cuxhaven, Germany facility, expanding early-to-late phase clinical
Vibalogics Updates U.S. Leadership Team contractpharma
April 01, 2021
Vibalogics, a global contract development and manufacturing organization (CDMO) specializing in the production of virotherapy products, has appointed Mike DiMeo to the executive board as CFO, while Judith Adair McCorry has joined as vice president of ...
Vibalogics Establishes U.S. Presence contractpharma
November 17, 2020
Vibalogics, a global contract development and manufacturing organization (CDMO), has initiated Phase I of its planned $150 million investment in a late-phase clinical and commercial virotherapy manufacturing facility near Boston, MA.
Vibalogics Appoints Global CEO to Lead U.S. Expansion contractpharma
September 17, 2020
Tom Hochuli takes the helm as the company accelerates its U.S. expansion and global growth strategy.
J&J signs Covid-19 vaccine manufacturing contract with Vibalogics pharmaceutical-technology
May 20, 2020
Johnson & Johnson (J&J) has signed a deal with contract development and manufacturing organisation (CDMO) Vibalogics for the manufacture of clinical trial material for a Covid-19 vaccine candidate being developed by J&J unit Janssen Pharmaceutical.
Vibalogics to Manufacture Clinical Material for Janssen contractpharma
May 15, 2020
CDMO to provide additional clinical trial material for COVID-19 vaccine candidate.
Ampersand to Acquire Vibalogics contractpharma
May 31, 2019
CDMO will expand capabilities to meet growing demand for development and manufacturing of complex viral products.
Vibalogics Increases Capacity for Virus Manufacturing contractpharma
May 16, 2019
New manufacturing line features 50 liter and 200 liter single use bioreactors and a Siemens process control system.